Evaluation of horse urine sample preparation methods for metabolomics using LC coupled to HRMS

被引:27
作者
Bennett, Daniel [1 ]
Gibbons, Jacqueline A. [2 ]
Mol, Roelof [3 ]
Ohtsu, Yoshiaki [4 ]
Williard, Clark [1 ]
机构
[1] InVentiv Hlth Clinical Lab Inc, Princeton, NJ 08540 USA
[2] Medivation Inc, San Francisco, CA 94105 USA
[3] Astellas Pharma Europe BV, NL-2300 AH Leiden, Netherlands
[4] Astellas Pharma Inc, Yodogawa Ku, Osaka 5328514, Japan
关键词
PROSTATE-CANCER;
D O I
10.4155/bio.13.324
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background:Horse urine is the medium of choice for the implementation of metabolomic approaches aimed at improving horse doping control. However, drug analysis in this biofluid is a challenging task due to the presence of large amounts of interfering compounds. Methodology & Results: A comparative study of sample preparation has been conducted to evaluate five sample-preparation methods, namely acetonitrile precipitation, proteinase K hydrolysis, membrane filtration and sample dilution with water by factors of five and 20, for metabolome analysis using liquid chromatography coupled to high resolution mass spectrometry. Assessment was performed at both global and targeted levels, by using a few thousand features obtained from peak detection software, and internal standards and 100 annotated or identified metabolites. Conclusion: By considering the number of detected signals, their intensity and their detection repeatability, acetonitrile precipitation was selected as the most efficient sample-preparation method for the analysis of horse urine metabolome in liquid chromatography coupled to high resolution mass spectrometry conditions.
引用
收藏
页码:737 / 744
页数:8
相关论文
共 7 条
  • [1] [Anonymous], 2001, GUID IND BIOAN METH
  • [2] Assessing the matrix effects of hemolyzed samples in bioanalysis
    Hughes, Nicola C.
    Bajaj, Navgeet
    Fan, Juan
    Wong, Ernest Y. K.
    [J]. BIOANALYSIS, 2009, 1 (06) : 1057 - 1066
  • [3] Lowes S, 2011, BIOANALYSIS, V3, P1323, DOI [10.4155/bio.11.135, 10.4155/BIO.11.135]
  • [4] Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
    Scher, Howard I.
    Fizazi, Karim
    Saad, Fred
    Taplin, Mary-Ellen
    Sternberg, Cora N.
    Miller, Kurt
    de Wit, Ronald
    Mulders, Peter
    Chi, Kim N.
    Shore, Neal D.
    Armstrong, Andrew J.
    Flaig, Thomas W.
    Flechon, Aude
    Mainwaring, Paul
    Fleming, Mark
    Hainsworth, John D.
    Hirmand, Mohammad
    Selby, Bryan
    Seely, Lynn
    de Bono, Johann S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (13) : 1187 - 1197
  • [5] Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study
    Scher, Howard I.
    Beer, Tomasz M.
    Higano, Celestia S.
    Anand, Aseem
    Taplin, Mary-Ellen
    Efstathiou, Eleni
    Rathkopf, Dana
    Shelkey, Julia
    Yu, Evan Y.
    Alumkal, Joshi
    Hung, David
    Hirmand, Mohammad
    Seely, Lynn
    Morris, Michael J.
    Danila, Daniel C.
    Humm, John
    Larson, Steve
    Fleisher, Martin
    Sawyers, Charles L.
    [J]. LANCET, 2010, 375 (9724) : 1437 - 1446
  • [6] Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
    Tran, Chris
    Ouk, Samedy
    Clegg, Nicola J.
    Chen, Yu
    Watson, Philip A.
    Arora, Vivek
    Wongvipat, John
    Smith-Jones, Peter M.
    Yoo, Dongwon
    Kwon, Andrew
    Wasielewska, Teresa
    Welsbie, Derek
    Chen, Charlie Degui
    Higano, Celestia S.
    Beer, Tomasz M.
    Hung, David T.
    Scher, Howard I.
    Jung, Michael E.
    Sawyers, Charles L.
    [J]. SCIENCE, 2009, 324 (5928) : 787 - 790
  • [7] Quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand binding assays
    Viswanathan, C. T.
    Bansal, Surendra
    Booth, Brian
    DeStefano, Anthony J.
    Rose, Mark J.
    Sailstad, Jeffrey
    Shah, Vinod P.
    Skelly, Jerome P.
    Swann, Patrick G.
    Weiner, Russell
    [J]. PHARMACEUTICAL RESEARCH, 2007, 24 (10) : 1962 - 1973